Enantone

DRUG3 trials

Sponsors

Takeda, Lee's Pharmaceutical Limited, Azienda Ospedaliero-Universitaria di Modena

Conditions

AdenomyosisCentral Precocious PubertyProstate Cancer

Phase 4

Adenomyosis and ART

Azienda Ospedaliero-Universitaria di ModenaAdenomyosis

Start: 2023-03-27End: 2025-03-31Target: 500Updated: 2023-07-10

Unknown Phase

A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

CompletedNCT02993926

TakedaCentral Precocious Puberty

Start: 2017-06-24End: 2018-09-30Updated: 2022-03-16

Comparison of a Novel Leuprolide With Market Leuprolide

Lee's Pharmaceutical LimitedProstate Cancer

Start: 2018-08-01End: 2018-12-31Target: 48Updated: 2018-09-10